Big pharma craves slice of AI-based RNA drug discovery

With new funding, Atomic AI envisions RNA as the next frontier in drug discovery

$35 Million Series A Financing to Advance AI-driven RNA Structure Platform for Treating Undruggable Diseases

Atomic AI Founder Raphael Townshend chosen for 30 Under 30

Atomic Rotationally Equivariant Scorer

Stanford machine learning algorithm predicts biological structures more accurately than ever before

Geometric deep learning of RNA structure